
FDA-approved gout drug shows promise in fighting COVID-19
Fox News
A gout drug approved by the U.S. Food and Drug Administration (FDA) could reportedly show promise in fighting the coronavirus.
The school noted that probenecid is primarily used to treat gout and has been on the market for more than 40 years, with minimal side effects to patients.
"There’s really nothing out there to safely fight these viruses," Ralph Tripp, lead author of the study and GRA Eminent Scholar of Vaccine and Therapeutic Studies in UGA’s College of Veterinary Medicine, said in a statement. "This antiviral works for all RNA respiratory viruses we tested, including SARS-CoV-2. RSV, coronavirus and flu all circulate in the same season. Bottom line is you can potentially reduce infection and disease using this one oral drug."
More Related News